Nolomirole HCl

CAS No. 138531-51-8

Nolomirole HCl( —— )

Catalog No. M34670 CAS No. 138531-51-8

Nolomirole HCl (CHF 1035) is a novel selective dopamine agonist with oral activity and inhibitory effects on norepinephrine release, which can be used to study mild chronic heart failure.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1112 In Stock
25MG 1729 In Stock
50MG 2213 In Stock
100MG 2883 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nolomirole HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Nolomirole HCl (CHF 1035) is a novel selective dopamine agonist with oral activity and inhibitory effects on norepinephrine release, which can be used to study mild chronic heart failure.
  • Description
    Nolomirole HCl (CHF 1035) is a novel selective dopamine agonist with oral activity and inhibitory effects on norepinephrine release, which can be used to study mild chronic heart failure.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor | Norepinephrine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    138531-51-8
  • Formula Weight
    369.88
  • Molecular Formula
    C19H28ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.O=C(OC1=CC=C2C(=C1OC(=O)C(C)C)CCC(NC)C2)C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Miriplatin

    Miriplatin (SM-11355) is a platinum complex used in TACE that has promise for the therapy of hepatocellular carcinoma (HCC).

  • FAUC 346

    FAUC 346 is a highly selective D3 partial agonist with EC50 of 1.5 nM, FAUC 346 with an inhibitory effect on cocaine-seeking behavior.

  • carfenazine

    carfenazine targets the Dopamine receptor and is used for schizophrenia research.